Monday, 31 August 2026European Markets

EURASIA FONC INV Stock Slides By 16% In The Last 5 Sessions

Loading stream...

(vianews) - shares of eurasia fonc inv (cac 40: efi.pa) dropped by a staggering 16.2% in 5 sessions from €0.36 to €0.30 at 17:55 est on friday, following the last session's downward trend. cac 40 is jumping 0.5% to €7,421.67, after three consecutive sessions in a row of gains.

about eurasia fonc inv

eurasia fonciere investissements société anonyme owns, develops, and manages corporate and commercial real estate assets. the company was formerly known as mb retail europe and changed its name to eurasia fonciere investissements société anonyme in january 2012. the company was founded in 1984 and is headquartered in paris, france. eurasia fonciere investissements société anonyme is a subsidiary of eurasia groupe sa.

volatility

eurasia fonc inv's last week, last month's, and last quarter's current intraday variation average was a negative 9.33%, a negative 2.00%, and a positive 14.04%.

eurasia fonc inv's highest amplitude of average volatility was 10.00% (last week), 11.31% (last month), and 14.04% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, eurasia fonc inv's stock is considered to be oversold (<=20).

volume

today's last reported volume for eurasia fonc inv is 200 which is 284.61% above its average volume of 52.

more news about eurasia fonc inv (efi.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com